Forge Biologics
在场
Forge Biologics 的所有者是 Ajinomoto.
是其中之一......
Ajinomoto 是一家在股票代码 2802 (JP) 下上市的公司。
Ajinomoto 在 3 个国家有直接业务。Ajinomoto 拥有 5家子公司，其中包括 Ajinomoto BioPharma、Ajinomoto BioPharma Europe 和 Ajinomoto Cambrooke。
他们在：
涉及Ajinomoto的并购和融资。
- Ajinomoto has announced the acquisition of Forge Biologics (公布2023十一月16号).
高管
查看带有其 21 名主要高管的组织结构图
Forge Biologics 搜索最多的简介
- John Maslowski, President, Chief Executive Officer and Director
- Yasuyuki Otake, Chairman of the Board
- Magdalena Tyrpien, Chief Business Officer
高管在Forge Biologics变化
- Timothy Miller, Director, Chief Executive Officer and President, 已经离开公司 (新闻发布的2024九月11号).
- John Maslowski 曾任 Chief Commercial Officer, 现升职为 President, Chief Executive Officer and Director (新闻发布的2024九月11号).
创建提醒
跟踪 Forge Biologics 的高管变动
生物技术
Ajinomoto 拥有 2,316 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Forge Biologics 的最新新闻稿
- MDA Kickstart Program Receives FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Congenital Myasthenic Syndrome | Muscular Dystrophy Association
- Forge Biologics Unveils FUEL Platform with Advanced AAV Production Technologies - PharmaSource
- Forge Biologics Announces the FUEL™ AAV Manufacturing Platform to Provide Developers with a More Efficient Solution for Gene Therapy Production
- Forge Biologics Launches FUEL Manufacturing Platform
- Ohio Life Sciences provides $250,000 to Columbus State to accelerate biotechnology career entry | Columbus State Community College
- Forge Biologics Names New CEO
- Analytics Key to AV and AAV Manufacturing
- In Brief This Week: Inocras, Forge Biologics, Centogene, Gilead Sciences, Cabaletta Bio
- Ohio builds on healthcare innovation legacy with big 2023 — OhioTechNews.com
- Axios Pro Rata: Twitter Tuesday
- View more press releases Close
通过电子邮件
